Jonne Mm Laurila

Jonne Mm Laurila

Auto-generated profile, based on publicly available information

Jonne Mm Laurila

Department of Pharmacology, Drug Development and Therapeutics, University of Turku, and Turku University Hospital, FI-20014 Turku, Finland

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2005 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
JRJori O Ruuskanen
Jori O Ruuskanen
JLJonne Laurila
Jonne Laurila
HXHenri Xhaard
Henri Xhaard
VRVille‐Veikko Rantanen
Ville‐Veikko Rantanen
KVKaroliina Vuoriluoto
Karoliina Vuoriluoto
MSMika Scheinin
Mika Scheinin

1 August 2010 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
ULUlrika Lind
Ulrika Lind
MRMagnus Alm Rosenblad
Magnus Alm Rosenblad
LFLinda Hasselberg Frank
Linda Hasselberg Frank
SFSusanna Falkbring
Susanna Falkbring
LBLars Brive
Lars Brive
ABAnders Blomberg
Anders Blomberg
G protein-coupled octopamine receptors of insects and other invertebrates represent counterparts of adrenoceptors in vertebrate animals. The α2-adrenoceptor agonist medetomidine, which is in clinical use as a veterinary sedative agent, was discovered to inhibit the settling process of barnacles, an important step in the ontogeny of this crustacean species. Settling of barnacles onto ship hulls leads to biofouling that has many harmful practical consequences, and medetomidine is currently under development as a novel type of antifouling agent. We now report that medetomidine induces hyperactivity in the barnacle larvae to disrupt the settling process. To identify the molecular targets of medetomidine, we cloned five octopamine receptors from the barnacle Balanus improvisus. We show by phylogenetic analyses that one receptor (BiOctα) belongs to the α-adrenoceptor-like subfamily, and the other four (BiOctβ-R1, BiOctβ-R2, BiOctβ-R3, and BiOctβ-R4) belong to the β-adrenoceptor-like octopamine receptor subfamily. Phylogenetic analyses also indicated that B. improvisus has a different repertoire of β-adrenoceptor-like octopamine receptors than insects. When expressed in CHO cells, the cloned receptors were activated by both octopamine and medetomidine, resulting in increased intracellular cAMP or calcium levels. Tyramine activated the receptors but with much lesser potency than octopamine. A hypothesis for receptor discrimination between tyramine and octopamine was generated from a homology three-dimensional model. The characterization of B. improvisus octopamine receptors is important for a better functional understanding of these receptors in crustaceans as well as for practical applications in development of environmentally sustainable antifouling agents.

1 May 2005 in Journal of Structural Biology
Verified
Journal Article
Closed access
HXHenri Xhaard
Henri Xhaard
TNTommi Nyrönen
Tommi Nyrönen
VRVille-Veikko Rantanen
Ville-Veikko Rantanen
JRJori O. Ruuskanen
Jori O. Ruuskanen
JLJonne Laurila
Jonne Laurila
MJMark S. Johnson
Mark S. Johnson

1 August 2007 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
JLJ M M Laurila
J M M Laurila
HXH Xhaard
H Xhaard
JRJ O Ruuskanen
J O Ruuskanen
MRM J M Rantanen
M J M Rantanen
HKH K Karlsson
H K Karlsson
MSM Scheinin
M Scheinin

1 July 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
JVJelica Vucicevic
Jelica Vucicevic
TSTatjana Srdic-Rajic
Tatjana Srdic-Rajic
MPMARCO PIERONI
MARCO PIERONI
JLJonne M.M. Laurila
Jonne M.M. Laurila
VPVladimir Perovic
Vladimir Perovic
VVveljko veljkovic
veljko veljkovic

1 January 2011 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
FSFranciszek Saczewski
Franciszek Saczewski
AKAnita Kornicka
Anita Kornicka
AHAlan L. Hudson
Alan L. Hudson
SLShayna Laird
Shayna Laird
MSMika Scheinin
Mika Scheinin
MGMaria Gdaniec
Maria Gdaniec